Arthur P. Bertolino

2014

In 2014, Arthur P. Bertolino earned a total compensation of $2.6M as Executive Vice President and Chief Medical Officer at Revance Therapeutics.

Compensation breakdown

Bonus$50,000
Non-Equity Incentive Plan$35,249
Option Awards$1,477,236
Salary$129,182
Stock Awards$904,444
Total$2,596,110

Bertolino received $1.5M in option awards, accounting for 57% of the total pay in 2014.

Bertolino also received $50K in bonus, $35.2K in non-equity incentive plan, $129.2K in salary and $904.4K in stock awards.

Rankings

In 2014, Arthur P. Bertolino's compensation ranked 3,515th out of 13,032 executives tracked by ExecPay. In other words, Bertolino earned more than 73.0% of executives.

ClassificationRankingPercentile
All
3,515
out of 13,032
73rd
Division
Manufacturing
1,239
out of 4,966
75th
Major group
Chemicals And Allied Products
401
out of 1,686
76th
Industry group
Drugs
311
out of 1,365
77th
Industry
Pharmaceutical Preparations
253
out of 1,043
76th
Source: SEC filing on March 26, 2015.

Bertolino's colleagues

We found three more compensation records of executives who worked with Arthur P. Bertolino at Revance Therapeutics in 2014.

2014

L Browne

Revance Therapeutics

Chief Executive Officer

2014

Jacob Waugh

Revance Therapeutics

Chief Scientific Officer

2014

Lauren Silvernail

Revance Therapeutics

Chief Financial Officer

In-depth

You may also like